Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.

PubWeight™: 2.69‹?› | Rank: Top 1%

🔗 View Article (PMC 1492876)

Published in Ann Surg on January 01, 1987

Authors

T Nagao, S Inoue, S Goto, T Mizuta, Y Omori, N Kawano, Y Morioka

Articles citing this

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59

Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg (1991) 2.46

Major hepatic resection under total vascular exclusion. Ann Surg (1989) 2.29

Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg (1993) 2.06

Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83

Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg (1996) 1.73

Current treatment modalities for hepatocellular carcinoma. Ann Surg (1994) 1.59

Postoperative recurrence of hepatocellular carcinoma. Ann Surg (1990) 1.55

Should hepatomas be treated with hepatic resection or transplantation? Cancer (1999) 1.54

Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg (1996) 1.43

Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg (2003) 1.35

Segmental liver resection using ultrasound-guided selective portal venous occlusion. Ann Surg (1989) 1.32

Elective and emergency hepatic resection. Determinants of operative mortality and morbidity. Ann Surg (1991) 1.21

Clinical management of recurrent hepatocellular carcinoma. Ann Surg (1995) 1.16

Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg (2002) 1.16

Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr (2010) 1.10

The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg (1991) 1.05

Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg (2002) 1.04

Rationale of surgical management for recurrent hepatocellular carcinoma. Ann Surg (1993) 1.04

Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure? HPB (Oxford) (2016) 1.00

Hepatectomy for huge hepatocellular carcinoma in 634 cases. World J Gastroenterol (2006) 0.96

Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg (1993) 0.96

Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination. Korean J Radiol (2012) 0.95

Clinical significance of surgical resection of metastatic lymph nodes from hepatocellular carcinoma. Surg Today (2014) 0.94

Controlled low central venous pressure reduces blood loss and transfusion requirements in hepatectomy. World J Gastroenterol (2014) 0.92

High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clin Exp Metastasis (2009) 0.92

High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol (2015) 0.90

Effect of infra-hepatic inferior vena cava clamping on bleeding during hepatic dissection: a prospective, randomized, controlled study. World J Surg (2008) 0.90

Renal function after low central venous pressure-assisted liver resection: assessment of 2116 cases. HPB (Oxford) (2014) 0.90

Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report. Surg Today (1997) 0.90

Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection. Ann Surg (1989) 0.89

Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma? World J Gastroenterol (2003) 0.87

Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy. Oncologist (2012) 0.86

Low preoperative platelet counts predict a high mortality after partial hepatectomy in patients with hepatocellular carcinoma. World J Gastroenterol (2005) 0.86

Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis. World J Gastroenterol (2011) 0.86

The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs). Int J Nanomedicine (2012) 0.86

Factors influencing blood transfusion during adult liver transplantation. Ann R Coll Surg Engl (1993) 0.86

Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol (2007) 0.86

Hepatic radioembolization as a bridge to liver surgery. Front Oncol (2014) 0.85

Encapsulated hepatocellular carcinoma: CT-pathologic correlations. Eur Radiol (2006) 0.84

Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol (2012) 0.83

Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma. World J Gastroenterol (2010) 0.82

Is the expression of gamma-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma? World J Gastroenterol (2003) 0.81

Hepatic resection for hepatocellular carcinoma patients on hemodialysis for uremia: a nationwide cohort study. World J Surg (2013) 0.81

Safety of hepatectomy for elderly patients with hepatocellular carcinoma. World J Gastroenterol (2014) 0.79

Comparison of the effects of propofol and pentobarbital on hydrogen peroxide-stimulated hepatic SNU761 cells. Korean J Anesthesiol (2010) 0.79

Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol (1992) 0.79

Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma. World J Gastroenterol (2005) 0.79

Long-term prognosis of surgical patients with hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.78

Complex hepatectomy under total vascular exclusion of the liver: impact of ischemic preconditioning on clinical outcomes. World J Surg (2013) 0.76

Comparison of survival outcomes after anatomical resection and non-anatomical resection in patients with hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg (2015) 0.75

Influence of metabolic and other clinicopathologic factors on the prognosis of patients with hepatocellular carcinoma undergoing hepatic resection. Korean J Hepatobiliary Pancreat Surg (2014) 0.75

Articles cited by this

A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika (1965) 14.16

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67

Experience with 150 liver resections. Ann Surg (1983) 3.01

Major hepatic resection. A 25-year experience. Ann Surg (1983) 2.55

Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery (1986) 1.98

Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis. Gut (1978) 1.73

The surgical management of primary carcinoma of the liver. World J Surg (1982) 1.64

Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer (1984) 1.57

Estimation of the functional reserve of human liver. Ann Surg (1974) 1.49

Primary malignant tumors of the liver. Cancer (1971) 1.39

Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer (1981) 1.19

Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC. Cancer (1985) 1.18

One hundred hepatic resections. Indications and operative results. Ann Surg (1985) 1.14

Hepatic resection in the treatment of hepatocellular carcinoma: report of 60 cases. Br J Surg (1985) 1.11

Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q J Med (1984) 1.03

Factors influencing primary liver cancer resection survival rate. Chin Med J (Engl) (1981) 0.97

Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan. Cancer (1984) 0.91

[Hepatocellular carcinoma in France. Clinical, biological and virological aspects in 197 patients]. Gastroenterol Clin Biol (1985) 0.86

Articles by these authors

KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00

KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62

DBGET/LinkDB: an integrated database retrieval system. Pac Symp Biocomput (1998) 24.06

Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55

Reconstruction of amino acid biosynthesis pathways from the complete genome sequence. Genome Res (1998) 7.03

A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58

Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (1998) 5.63

In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother (1983) 5.45

A heuristic graph comparison algorithm and its application to detect functionally related enzyme clusters. Nucleic Acids Res (2000) 4.53

Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1993) 4.04

Geoelectric potential changes: possible precursors to earthquakes in Japan. Proc Natl Acad Sci U S A (2000) 3.93

New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. J Bacteriol (1981) 3.65

Metalloproteinase-mediated release of human Fas ligand. J Exp Med (1995) 3.53

Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother (1979) 3.51

In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Antimicrob Agents Chemother (1984) 3.35

Electric and magnetic phenomena observed before the volcano-seismic activity in 2000 in the Izu Island Region, Japan. Proc Natl Acad Sci U S A (2002) 3.18

Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids. Antimicrob Agents Chemother (1978) 3.12

Computation with the KEGG pathway database. Biosystems (1998) 2.79

Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet (1998) 2.77

Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg (2012) 2.72

Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63

The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol (1996) 2.43

Twenty-year changes in the prevalence of overweight in Japanese adults: the National Nutrition Survey 1976-95. Obes Rev (2002) 2.35

Comparative study on adhesive performance of functional monomers. J Dent Res (2004) 2.32

Biotin-containing intranuclear inclusions in endometrial glands during gestation and puerperium. Am J Clin Pathol (1993) 2.21

Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration. J Antibiot (Tokyo) (1970) 2.15

Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem (1995) 2.11

The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients. Support Care Cancer (1999) 2.10

Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene (2006) 2.10

A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis (2011) 2.02

Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology (2008) 2.00

Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett (1994) 1.99

Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A (1985) 1.97

Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood (1992) 1.97

In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. Antimicrob Agents Chemother (Bethesda) (1969) 1.96

Early gastric cancer. Endoscopic diagnosis of depth of invasion. Dig Dis Sci (1990) 1.94

Liquid-gated interface superconductivity on an atomically flat film. Nat Mater (2009) 1.92

Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1. Cell Death Differ (2005) 1.90

In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116. Antimicrob Agents Chemother (1992) 1.90

Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull (2001) 1.90

Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet (1992) 1.87

Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res (1998) 1.85

Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med (2001) 1.85

A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am J Respir Crit Care Med (2001) 1.83

Four-year water degradation of total-etch adhesives bonded to dentin. J Dent Res (2003) 1.83

p38 mitogen-activated protein kinase can be involved in transforming growth factor beta superfamily signal transduction in Drosophila wing morphogenesis. Mol Cell Biol (1999) 1.83

Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum (1985) 1.82

Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord (1993) 1.82

Role of root hairs and lateral roots in silicon uptake by rice. Plant Physiol (2001) 1.81

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med (2000) 1.79

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. Aliment Pharmacol Ther (2008) 1.77

Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum Genet (1999) 1.77

The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.77

Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology (1997) 1.74

Cloning vehicles for the homologous Bacillus subtilis host-vector system. Gene (1980) 1.74

The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem Biophys Res Commun (1998) 1.71

Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol Med (1999) 1.70

Diverticular disease of the colon in Japan. A review of 615 cases. Dis Colon Rectum (1984) 1.70

Comparison of changes in jugular venous bulb oxygen saturation and cerebral oxygen saturation during variations of haemoglobin concentration under propofol and sevoflurane anaesthesia. Br J Anaesth (2004) 1.69

G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature (2000) 1.68

Cloning of 3-isopropylmalate dehydrogenase gene of an extreme thermophile and partial purification of the gene product. J Biochem (1981) 1.68

Drug-sensitivity of El Tor vibrio strains isolated in the Philippines in 1964 and 1965. Bull World Health Organ (1967) 1.67

Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro. J Neurosci (1996) 1.67

Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol (2004) 1.66

Sophorolipids from Torulopsis bombicola: possible relation to alkane uptake. Appl Environ Microbiol (1982) 1.65

Juvenile amyotrophy of the distal upper extremity: pathologic findings of the dura mater and surgical management. Spine (Phila Pa 1976) (1997) 1.64

Effect of decompression enlargement laminoplasty for posterior shifting of the spinal cord. Spine (Phila Pa 1976) (1999) 1.63

Alcohol oxidases of Kloeckera sp. and Hansenula polymorpha. Catalytic properties and subunit structures. Eur J Biochem (1976) 1.61

Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase. Antimicrob Agents Chemother (1979) 1.61

Diagnosis and treatment of Hirschsprung's disease in Japan. An analysis of 1628 patients. Ann Surg (1984) 1.61

Terminal sedation for existential distress. Am J Hosp Palliat Care (2002) 1.61

Monomer-solvent phase separation in one-step self-etch adhesives. J Dent Res (2005) 1.60

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer (2001) 1.58

Isolation of tannin-degrading lactobacilli from humans and fermented foods. Appl Environ Microbiol (2000) 1.56

Postoperative recurrence of hepatocellular carcinoma. Ann Surg (1990) 1.55

Experimental stroke in the female diabetic, db/db, mouse. J Cereb Blood Flow Metab (2001) 1.55

Determinants of the sensation of thirst in terminally ill cancer patients. Support Care Cancer (2001) 1.55

Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int (2001) 1.54

Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics. J Antibiot (Tokyo) (1979) 1.54

Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature (1997) 1.54

Immunoreactive alpha A crystallin in rat non-lenticular tissues detected with a sensitive immunoassay method. Biochim Biophys Acta (1991) 1.54

TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP. Oncogene (2011) 1.53

New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation (2001) 1.53

Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem (1992) 1.52

True median cleft of the upper lip associated with three pedunculated club-shaped skin masses. Plast Reconstr Surg (1985) 1.51

The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism (2001) 1.51

Diamond-Blackfan anemia associated with Treacher-Collins syndrome. Pediatr Hematol Oncol (1993) 1.51

Validity of the palliative performance scale from a survival perspective. J Pain Symptom Manage (1999) 1.51

L-arabinose selectively inhibits intestinal sucrase in an uncompetitive manner and suppresses glycemic response after sucrose ingestion in animals. Metabolism (1996) 1.49

Regressing nevoid nail melanosis in childhood. Dermatology (1993) 1.49

Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res (1990) 1.49

Effects of conjugated linoleic acid on serum leptin concentration, body-fat accumulation, and beta-oxidation of fatty acid in OLETF rats. Nutrition (2001) 1.48

Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer (1987) 1.48

In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later. Pediatrics (1967) 1.48

Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Lab Invest (1974) 1.48

A technique for complete thymectomy in adult rats. J Immunol Methods (1994) 1.47